Skip to main content
News Kolanus 04.2022
ImmunoSensation speaker Prof. Dr. Waldemar Kolanus (left) and Dr. Stefan Weise from the LIMES Institute (right).
© Barbara Fomman / Uni Bonn

News categories: Publication

Surprising finding on the cause of hydrocephalus

Prof. Dr. Waldemar Kolanus, speaker of the Cluster of Excellence ImmunoSensation2, together with an international team of scientists, shows that hydrocephalus is often caused by disrupted brain development.

Hydrocephalus in children often has completely different causes than previously assumed. This is the conclusion of an international study with a substantial participation by the University of Bonn. The researchers identified a series of mutations that cause disruption of early brain development. The characteristic enlargements of the fluid-filled cavities in the brain are a consequence of this. The study was led by Yale, Harvard and Bonn Universities; its findings also have implications for the diagnosis and treatment of this serious condition. The results are published in the journal Nature Neuroscience.

One in 1,000 children is born with hydrocephalus. The serious condition is the most common reason for brain surgery in childhood. Nevertheless, those affected often suffer from intellectual and motor impairments for the rest of their lives.

A paradigm shift

In hydrocephalus, the fluid-filled cavities in the brain, the ventricles, are significantly enlarged. This significantly increases the intracranial pressure. The cause is thought to be disruptions of the cerebrospinal fluid balance. This fluid surrounds the brain and removes toxins. It also acts like a cushion to protect the brain from shocks and ensures that the cavities do not collapse. "Until now, it was thought that in hydrocephalus too much CSF was formed or too little was discharged, or that its onward transport was simply impaired," explains Prof. Dr. Waldemar Kolanus of the LIMES Institute at the University of Bonn. "However, our results now point in a different direction."

93 risk genes identified

In children, the condition is usually genetic; however, the hereditary factors responsible are only partially known. The researchers from Harvard and Yale therefore sequenced the genome of almost 500 patients and compared it with the genetic material of healthy individuals. In the process, they came across 93 genes in which mutations lead to hydrocephalus. "Surprisingly, none of these genes are involved in any way in CSF production or transport," emphasizes Kolanus' collaborator Dr. Stefan Weise, one of the two lead authors of the study. "Instead, they seem to be mostly related to brain development."

One hereditary trait that was particularly often mutated in affected individuals is the TRIM71 gene. "We have been studying this gene here in Bonn for several years," Kolanus says. "This is also the reason why our U.S. colleagues contacted us." The international team also introduced the mutations they found into the TRIM71 gene in mice. The model animals then also developed hydrocephalus.

"We then used stem cells here in Bonn to reproduce very early events of brain development in cell culture," Kolanus explains. "This allowed us to show that hydrocephalus mutations of TRIM71 specifically affect these functions. In the future, we will decipher these processes even better with the help of organoids, which are cell clusters that roughly resemble a very simple brain."

Mutations probably make the brain more mechanically unstable

The mutations presumably damage the so-called neuroepithelial cells. These line the fluid cavities in the brain from the inside. "We assume that these changes make the neuroepithelium thinner and more mechanically flexible, and that the cavities increase as a result," Stefan Weise believes. "This can then lead to increased cerebrospinal fluid accumulation and thus also to increased intracranial pressure." In this case, hydrocephalus is therefore a consequence of neurodevelopmental disorders in early childhood, which in turn are responsible for the cognitive impairments of the young patients.

Usually, hydrocephalus surgery involves the use of a so-called shunt system through which the excess cerebrospinal fluid can be drained. This reduces the pressure in the skull, and accompanying symptoms such as headaches or visual disturbances disappear. However, the cognitive and intellectual limitations usually persist. "Our results explain why this is the case in congenital hydrocephalus," Kolanus says. "The damage doesn't come from increased pressure, but occurs much earlier, during embryonic brain development."

This finding might also have therapeutic consequences. For instance, the insertion of the shunt system is not without risks. Nevertheless, many medical professionals advise it because they fear that the brain abnormalities will otherwise increase. “However, the procedure is probably not useful in all cases in children," says Kolanus.

It may in future also be possible to diagnose hydrocephalus before birth using genetic testing. Targeted early intervention could then possibly prevent some damage. However, the condition is unlikely to be curable in the foreseeable future. "This would require gene therapy of the embryo in the womb," Kolanus explains. "Right now, it would be way too risky and also legally impossible."

The researcher is one of the spokespersons for the Cluster of Excellence ImmunoSensation2 and the Transdisciplinary Research Area (TRA) “Life and Health” at the University of Bonn. "For this project, which as so often relies on the cooperation of many groups, I was able to draw on the excellent networks in the Cluster of Excellence and the TRA," he adds.


Participating institutions and funding

In addition to the Universities of Yale, Harvard and Bonn, as well as the German Center for Neurodegenerative Diseases (DZNE) in Bonn and the Humboldt University of Berlin, various universities and clinics in Great Britain and the USA were involved in the study. The work was financially supported by the National Institutes of Health (USA) and the German Research Foundation (DFG), among others.


Publication

Phan Q. Duy, Stefan C. Weise et al.: Impaired neurogenesis alters brain biomechanics in a neuroprogenitor-based genetic subtype of congenital hydrocephalus; Nature Neuroscience; https://doi.org/10.1038/s41593-022-01043-3


Contact

Prof. Dr. Waldemar Kolanus
Life and Medical Sciences Institute (LIMES) at the University of Bonn
Phone: +49-228-7362790
Email: wkolanus@uni-bonn.de

Related news

News categories: Publication

Kato group publishes article in Science Advances

Dysregulation of regulatory T cell homeostasis by ADAR1 deficiency and chronic MDA5 signaling
View entry
Bartok & Günther

News categories: Publication

False alarm of the immune system during muscle disease

Researchers at the University Hospitals of Dresden and Bonn of the DFG Transregio 237 and from the Cluster of Excellence ImmunoSensation2 at the University of Bonn have made progress clarifying why patients with myotonic dystrophy 2 have a higher tendency to develop autoimmune diseases. Their goal is to understand the development of the disease, and their research has provided new, potential therapeutic targets. The results of the study have now been published in the renowned journal "Nature Communications".
View entry
Scientists from the University Hospital Bonn and the University of Bonn discover an important membrane transport mechanism in pathogenic bacteria. PD Dr. Gregor Hagelueken (left) and Philipp Hendricks (right) are part of the research team.

News categories: Publication

Bonn scientists unravel the working mechanism of an important membrane transport system of pathogenic bacteria

Researchers from the University Hospital of Bonn and the University of Bonn in collaboration with the University of York studied an important class of bacterial membrane transporters and their interaction with soluble substrate binding proteins.
View entry

Back to the news overview